Following the results of a recent study which showed that Eli Lilly’s sepsis drug, Xigris, provided no better results in reducing mortality than that of a placebo, the pharmaceutical company announced it will pull the product from the market worldwide.

Both The European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have acknowledged that the drug’s manufacturer has informed them of the decision to pull activated drotrecogin alfa, otherwise known as Xigris, from pharmacy shelves.

Xigris is used to treat severe cases of sepsis in high-risk patients, but the drug’s efficacy has been questioned since it was authorized for use almost 10 years ago.

RESULTS & SETTLEMENTS

Frank M. Eidson P.A. has been tirelessly representing the rights of Central Florida victims since 1989.

$1.2 Million

Two surgeries for back injuries.

$1 Million

Fell from a roof while working.

$1.15 Million

Brain injury in a tractor-trailer crash.


Free, No Obligation Case Review.

Fill out our contact form below for your free, no obligation case review.

  • This field is for validation purposes and should be left unchanged.
Help provide wounded servicemen and women with therapeutic outdoor adventures. Like our Facebook page and we'll contribute $1 to Wounded Warriors Outdoors.

Contact Our Orlando Attorney

If you have been injured in an accident, turn to Frank M. Eidson P.A. Whether your case is a simple collision or a complicated auto wrongful death case, contact personal injury lawyer Frank Eidson today to schedule your free consultation.

407-245-2887